Eam Investors, LLC Standard Biotools Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.9 - $3.05 $900,565 - $1.45 Million	473,982 New	473,982 $1.37 Million
Q3 2019 Nov 13, 2019	SELL	$4.63 - $12.15 $1.02 Million - $2.69 Million	-221,082 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$11.49 - $14.17 $1.9 Million - $2.35 Million	-165,772 Reduced 42.85%	221,082 $2.72 Million
Q1 2019 May 13, 2019	BUY	$8.47 - $14.36 $1.27 Million - $2.15 Million	149,767 Added 63.17%	386,854 $5.14 Million
Q4 2018 Feb 13, 2019	BUY	$7.18 - $8.83 $1.7 Million - $2.09 Million	237,087 New	237,087 $2.04 Million
Q2 2018 Aug 03, 2018	SELL	$4.86 - $6.24 $381,772 - $490,176	-78,554 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$5.75 - $7.97 $451,685 - $626,075	78,554 New	78,554 $459,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.